October 5, 2022

Volume XII, Number 278

Rebecca L. Osowski

Rebecca L. Osowski is the director of healthcare compliance for Morgan Lewis's FDA and Healthcare Practice. Morgan Lewis's compliance representations encompass HHS OIG corporate integrity agreements for CIA implementation; Board and IRO compliance resources; DOJ deferred prosecution agreements; voluntary corporate compliance effectiveness reviews; healthcare professional arrangement reviews; corporate compliance policy development; and federal and state transparency and marketing compliance.

Ms. Osowski's corporate compliance engagements focus on assisting clients in developing and implementing practical and sustainable global compliant business practices, complying with government mandated requirements under CIAs and DPAs, voluntary arrangement reviews, compliance effectiveness assessments and corporate policy development. Ms. Osowski has deep industry knowledge, including involvement within AdvaMed, to help shape industry guidelines governing interactions between industry and health care professionals. She also has experience in the area of health industry transparency requirements (e.g., Physician Payment Sunshine Act) as well as similar state requirements (e.g., Massachusetts Pharmaceutical and Medical Device Manufacturer Code of Conduct, Vermont Gift Ban and Disclosure Law). Ms. Osowski's compliance career has involved serving as a healthcare compliance officer for a device company under both a DPA and CIA and as a consultant assisting clients in the development and implementation of corporate compliance best practices for a broad range of health industry sectors.

Articles in the National Law Review database by Rebecca L. Osowski